Does Foreign Patent Protection Increase the United States’ Trade of Pharmaceuticals with Developing Countries?
نویسنده
چکیده
The United States has been pushing for foreign patent protection through free trade agreements and the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). A gravity model using panel data from 1993 to 2007 suggests that foreign patent protection has not significantly increased the United States’ trade of pharmaceuticals. Other factors are strong determinants of the United States exports of pharmaceuticals. In particular, a developing country’s participation in the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) significantly increases U.S. exports.
منابع مشابه
Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals
There is growing international concern about the risks posed by direct-to-consumer advertising (DTCA) of prescription pharmaceuticals, including via the internet. Recent trade agreements negotiated by the United States, however, incorporate provisions that may constrain national regulation of DTCA. Some provisions explicitly mention DTCA; others enable foreign investors to seek compensation if ...
متن کاملSecrecy, Monopoly, and Access to Pharmaceuticals in International Trade Law: Protection of Marketing Approval Data Under the TRIPs Agreement
Among the many trade conoicts that divide the postindustrial economies of Europe, the United States, Japan, and the Commonwealth from the less information-driven economies of the rest of the world, one of the most consequential is the debate over how to balance access to medicines with the intellectual property protection demanded by their developers. Among the many facets of this debate is the...
متن کاملDrug Pricing Under Generic Competition: A Review of the Economics Literature
1 1. Introduction As a consequence of the TRIPS Agreement at the WTO, many developing countries have implemented or strengthened product patents in pharmaceuticals in recent years, though the Doha Declaration of 2001 clarified that the least developed WTO members may delay such implementation or enforcement of drug patents until 2016. TRIPS requires the provision of patents across virtually all...
متن کاملInvestments in Pharmaceuticals Before and After TRIPS
We examine the relationship between patent protection for pharmaceuticals and investment in development of new drugs. Patent protection has increased around the world as a consequence of the TRIPS Agreement, which specifies minimum levels of intellectual property protection for members of the World Trade Organization. It is generally argued that patents are critical for pharmaceutical research ...
متن کاملU.s. Infringement Liability for Foreign Sellers of Infringing Products
IMPORTATION AS AN EXCLUSIVE RIGHT ¶1 Making, selling, or using a U.S.-patented product or process in a foreign country does not infringe the United States patent. United States law cannot govern in other countries, and the patentee’s remedy is therefore dependent on the laws of the relevant foreign country. But when the patented product (or the product of the patented process) is brought into t...
متن کامل